Insider Transactions in Q1 2023 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 03
2023
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
12,286
-1.52%
|
$12,286
$1.81 P/Share
|
|
Feb 02
2023
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
9,504
-2.95%
|
$9,504
$1.83 P/Share
|
|
Feb 02
2023
|
Tamara L Joseph Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,394
-1.03%
|
$3,394
$1.86 P/Share
|
|
Feb 02
2023
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,394
-1.03%
|
$3,394
$1.86 P/Share
|
|
Feb 01
2023
|
Kamal Hamed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+35.85%
|
-
|
|
Feb 01
2023
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+45.23%
|
-
|
|
Feb 01
2023
|
Tamara L Joseph Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+44.77%
|
-
|
|
Feb 01
2023
|
Timothy Keutzer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+44.59%
|
-
|
|
Feb 01
2023
|
Ankit Mahadevia |
BUY
Grant, award, or other acquisition
|
Direct |
531,914
+39.64%
|
-
|